-Bearing Debt. Our Net Interest-Bearing Debt to Equity ratio was at 0.57x. PERFORMANCE BY BUSINESS Utilities Business Revenue from Sales and Services from Utilities Business in 1Q2018 of Baht 422.0 million
three months period ended 31 March 2018 and 2019 was THB 101.00 million and THB 54.04 million respectively, equivalent to a 46.50% decline. Cost of goods sold to sales revenue ratio slightly dropped from
purchase ordinary shares of Modern Pharma Company Limited ("Modern") in the proportion of 100% of the total shares from the existing shareholders with details as follows: 1. D/M/Y of the transaction The
quarter of 2018 was decreased from 26% to 22%. This is because product/service cost mix changed, with the proportion of cost of non-mobile top-up service increasing. Expenses and expenses to revenues from
quarter of 2020 increased from 19% to 22% due to the proportion of revenue of a former large customer with a low gross margin tended to continually decline. Q1’ 2020 Q1’ 2019 Increase (decrease) Million
businesses were offset by sharp decline in Specialty Chemicals margins. Annual production was 11 million tons (+20% YoY), mainly driven by contribution from our acquisitions in 2018 and consolidation of
sharp rise in crude oil prices. The segment achieved Reported EBITDA of US$379M largely due to positive impact from adjustments in contracts and inventory. Global demand for PET has risen significantly
of 2017 amounted of Baht 140.0 million, decreased by 30.0% when compared to the third quarter of 2016, high proportion of loan loss reserves ratio at 184.32%. Earnings per share for the third quarter
) -0.04 -0.13 Gross Margin -2.21% -22.86% Net Profit Margin -22.07% -62.45% Debt to Equity Ratio (Time) 4.36 4.36 Total Expenses Financial Performance of 3rd quarter for 9 months ended September 30, 2017